CommercialCoverageMedium impact
Dialysis (CPB 0541, reviewed 2026-08-26)
Aetna·Nephrology, Critical Care, Internal Medicine·Medical Policy
We identified it
Oct 1, 2026
Summary
Aetna has issued a comprehensive dialysis policy (CPB 0541) reviewed on 2026-08-26 that establishes medical necessity criteria for hemodialysis, peritoneal dialysis, home dialysis equipment/supplies, and vascular access procedures. The policy includes specific coverage for percutaneous AV fistula creation, portable hemodialysis systems (NxStage, Tablo), and detailed supply lists, while designating certain technologies as experimental/not covered (Crit-Line Monitor, bioengineered vessels, vitamin E-coated membranes, wearable machines).
Action Required
Immediately: Billing team must update system configuration and reference materials as follows: (1) Ensure CPT codes 36836 and 36837 are properly configured for percutaneous AV fistula creation claims with appropriate documentation validation; (2) Verify CPT 90935, 90937, 99512 and all listed HCPCS codes (A4216-A4737) are enabled for coverage when medical necessity criteria are met; (3) Configure system to DENY claims for experimental/non-covered services: CPT 0876T (duplex scan with computer-aided analysis), CPT 83529 (Interleukin-6 testing), and any codes related to bioengineered vessels, vitamin E-coated membranes, or wearable hemodialysis machines; (4) Update dialysis supply billing rules to enforce one-time 1-month emergency reserve supply limit; (5) Configure denial logic to reject dual water purification systems (deionization AND reverse osmosis on same member); (6) Ensure rental equipment repair charges are bundled into rental fees (deny standalone repair codes); (7) Train billing team to cross-reference CPB 0373, 0540, and 1028 for related policies on Crit-Line monitoring, heating devices, and Korsuva injections. Consequences of inaction: Claims will be inappropriately denied or allowed for non-covered services, resulting in revenue loss and compliance violations.